AC
NKTR icon

Armistice Capital’s Nektar Therapeutics NKTR Stock Holding History

Armistice Capital’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.6M Sell
578,000
-18,000
-3% -$1.02M 1.37% 21
2025
Q4 		$25.2M Buy
596,000
+328,000
+122% +$18.4M 0.62% 53
2025
Q3 		$15.2M Buy
268,000
+144,000
+116% +$4.77M 0.48% 71
2025
Q2 		$3.2M Buy
124,000
+54,933
+80% +$617K 0.12% 117
2025
Q1 		$704K Buy
69,067
+800
+1% +$10.5K 0.02% 174
2024
Q4 		$952K Buy
68,267
+1,600
+2% +$28.2K 0.02% 169
2024
Q3 		$1.3M Buy
66,667
+10,934
+20% +$208K 0.03% 167
2024
Q2 		$1.04M Buy
+55,733
New +$1.17M 0.03% 162

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return